These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11168424)

  • 1. Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3).
    Arza B; De Maeyer M; Félez J; Collen D; Lijnen HR
    Eur J Biochem; 2001 Feb; 268(3):826-31. PubMed ID: 11168424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
    Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the 46-kDa intermediates of matrix metalloproteinase 3 (stromelysin 1) obtained by site-directed mutation of phenylalanine 83.
    Benbow U; Butticè G; Nagase H; Kurkinen M
    J Biol Chem; 1996 May; 271(18):10715-22. PubMed ID: 8631880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostromelysin-1 (proMMP-3) stimulates plasminogen activation by tissue-type plasminogen activator.
    Arza B; Hoylaerts MF; Félez J; Collen D; Lijnen HR
    Eur J Biochem; 2000 Nov; 267(21):6378-84. PubMed ID: 11029580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
    Itoh Y; Binner S; Nagase H
    Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):645-51. PubMed ID: 7772054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
    Lijnen HR; De Cock F; Collen D
    Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate.
    Nagase H; Enghild JJ; Suzuki K; Salvesen G
    Biochemistry; 1990 Jun; 29(24):5783-9. PubMed ID: 2383557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740----Ala) and plasmin-resistant scu-PA (Lys158----Glu).
    Lijnen HR; Van Hoef B; Nelles L; Collen D
    J Biol Chem; 1990 Mar; 265(9):5232-6. PubMed ID: 1969415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3).
    Ugwu F; Lemmens G; Collen D; Lijnen HR
    Thromb Haemost; 1999 Sep; 82(3):1127-31. PubMed ID: 10494776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase 3 (stromelysin 1).
    Chen LC; Noelken ME; Nagase H
    Biochemistry; 1993 Oct; 32(39):10289-95. PubMed ID: 8399171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
    Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
    Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
    Okada Y; Gonoji Y; Naka K; Tomita K; Nakanishi I; Iwata K; Yamashita K; Hayakawa T
    J Biol Chem; 1992 Oct; 267(30):21712-9. PubMed ID: 1400481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3.
    Nagase H; Suzuki K; Morodomi T; Enghild JJ; Salvesen G
    Matrix Suppl; 1992; 1():237-44. PubMed ID: 1480033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of plasmin-mediated prostromelysin-1 activation by interaction of long chain unsaturated fatty acids with kringle 5.
    Huet E; Cauchard JH; Berton A; Robinet A; Decarme M; Hornebeck W; Bellon G
    Biochem Pharmacol; 2004 Feb; 67(4):643-54. PubMed ID: 14757164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical properties of recombinant mutants of nonglycosylated single chain urokinase-type plasminogen activator.
    Li XK; Lijnen HR; Nelles L; Hu MH; Collen D
    Biochim Biophys Acta; 1992 Sep; 1159(1):37-43. PubMed ID: 1390910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide.
    Galazka G; Windsor LJ; Birkedal-Hansen H; Engler JA
    Biochemistry; 1996 Aug; 35(34):11221-7. PubMed ID: 8780527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells.
    Morodomi T; Ogata Y; Sasaguri Y; Morimatsu M; Nagase H
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):603-11. PubMed ID: 1379048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cleavage of pro-urokinase type plasminogen activator by stromelysin-1.
    Orgel D; Schröder W; Hecker-Kia A; Weithmann KU; Kolkenbrock H; Ulbrich N
    Clin Chem Lab Med; 1998 Sep; 36(9):697-702. PubMed ID: 9804393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties.
    Okada Y; Morodomi T; Enghild JJ; Suzuki K; Yasui A; Nakanishi I; Salvesen G; Nagase H
    Eur J Biochem; 1990 Dec; 194(3):721-30. PubMed ID: 2269296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.